(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Groupon, Fastenal Company, and Walgreens Boots.

Rank	Financial Asset	Price	Change	Updated (EST)
1	Groupon (GRPN)	10.82	8.42%	2023-10-12 12:12:35
2	Fastenal Company (FAST)	59.99	7.11%	2023-10-12 12:11:57
3	Walgreens Boots (WBA)	24.00	6.17%	2023-10-12 12:15:15
4	Broadcom (AVGO)	912.57	4.35%	2023-10-12 12:10:48
5	Vmware (VMW)	178.00	3.8%	2023-10-12 12:59:21
6	KLA Corporation (KLAC)	500.76	3.76%	2023-10-12 12:50:34
7	Albemarle (ALB)	170.90	3.7%	2023-10-12 12:18:01
8	Owens (OI)	16.31	3.69%	2023-10-12 01:14:06
9	Paramount Group (PGRE)	4.52	3.67%	2023-10-12 05:12:04
10	Pampa Energia S.A. Pampa Energia S.A. (PAM)	40.94	3.41%	2023-10-12 03:09:05

The three biggest losers today are Gevo, FibroGen, and Hormel Foods.

Rank	Financial Asset	Price	Change	Updated (EST)
1	Gevo (GEVO)	1.07	-10.83%	2023-10-12 12:12:25
2	FibroGen (FGEN)	0.63	-10.4%	2023-10-12 12:12:05
3	Hormel Foods (HRL)	32.53	-10.23%	2023-10-12 12:20:18
4	Castle Biosciences (CSTL)	12.39	-9.03%	2023-10-12 12:15:57
5	Rayonier Advanced Materials (RYAM)	2.87	-8.89%	2023-10-12 15:23:05
6	American Public Education (APEI)	4.41	-8.51%	2023-10-12 12:10:40
7	Peloton (PTON)	5.01	-8.49%	2023-10-12 12:16:48
8	Pacific Biosciences of California (PACB)	8.27	-8.47%	2023-10-12 12:13:59
9	Nevro Corp. (NVRO)	17.27	-8.19%	2023-10-11 23:12:05
10	JD.com (JD)	27.99	-7.76%	2023-10-12 12:13:11

Winners today

1. Groupon (GRPN) – 8.42%

Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants; and first-party goods inventory. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.

NASDAQ ended the session with Groupon jumping 8.42% to $10.82 on Thursday, following the last session’s upward trend. NASDAQ dropped 0.63% to $13,574.22, after four sequential sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Groupon has a trailing twelve months EPS of $-3.41.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -309.27%.

More news about Groupon.

2. Fastenal Company (FAST) – 7.11%

Fastenal Company, together with its subsidiaries, engages in the wholesale distribution of industrial and construction supplies in the United States, Canada, Mexico, and internationally. It offers fasteners, and related industrial and construction supplies under the Fastenal name. The company's fastener products include threaded fasteners, bolts, nuts, screws, studs, and related washers, which are used in manufactured products and construction projects, as well as in the maintenance and repair of machines. It also offers miscellaneous supplies and hardware, including pins, machinery keys, concrete anchors, metal framing systems, wire ropes, strut products, rivets, and related accessories. The company serves the manufacturing market comprising original equipment manufacturers; maintenance, repair, and operations customers; and non-residential construction market, which includes general, electrical, plumbing, sheet metal, and road contractors. It also serves farmers, truckers, railroads, mining companies, schools, and retail trades; and oil exploration, production, and refinement companies, as well as federal, state, and local governmental entities. Fastenal Company was founded in 1967 and is headquartered in Winona, Minnesota.

NASDAQ ended the session with Fastenal Company rising 7.11% to $59.99 on Thursday, following the last session’s upward trend. NASDAQ dropped 0.63% to $13,574.22, after four sequential sessions in a row of gains, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Fastenal Company has a trailing twelve months EPS of $1.96.

PE Ratio

Fastenal Company has a trailing twelve months price to earnings ratio of 30.61. Meaning, the purchaser of the share is investing $30.61 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.25%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Fastenal Company’s EBITDA is 77.45.

Revenue Growth

Year-on-year quarterly revenue growth grew by 5.9%, now sitting on 7.24B for the twelve trailing months.

Volume

Today’s last reported volume for Fastenal Company is 10007800 which is 234.19% above its average volume of 2994610.

More news about Fastenal Company.

3. Walgreens Boots (WBA) – 6.17%

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. The company operates under the Walgreens and Duane Reade brands in the United States. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. The company operates retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

NASDAQ ended the session with Walgreens Boots rising 6.17% to $24.00 on Thursday while NASDAQ slid 0.63% to $13,574.22.

Earnings Per Share

As for profitability, Walgreens Boots has a trailing twelve months EPS of $-3.84.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.6%.

Sales Growth

Walgreens Boots’s sales growth for the current quarter is 0.6%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Aug 17, 2023, the estimated forward annual dividend rate is 1.92 and the estimated forward annual dividend yield is 8.51%.

Yearly Top and Bottom Value

Walgreens Boots’s stock is valued at $24.00 at 17:32 EST, way under its 52-week high of $42.29 and way higher than its 52-week low of $20.58.

More news about Walgreens Boots.

4. Broadcom (AVGO) – 4.35%

Broadcom Inc. designs, develops, and supplies various semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide. The company operates in two segments, Semiconductor Solutions and Infrastructure Software. It provides set-top box system-on-chips (SoCs); cable, digital subscriber line, and passive optical networking central office/consumer premise equipment SoCs; wireless local area network access point SoCs; Ethernet switching and routing custom silicon solutions; embedded processors and controllers; serializer/deserializer application specific integrated circuits; optical and copper, and physical layer devices; and fiber optic components and RF semiconductor devices. The company also offers RF front end modules and filter; Wi-Fi, Bluetooth, and global positioning system/global navigation satellite system SoCs; custom touch controllers; custom touch controllers; inductive charging; attached small computer system interface, and redundant array of independent disks controllers and adapters; peripheral component interconnect express; fiber channel host bus adapters; read channel based SoCs; custom flash controllers; preamplifiers; optocouplers, industrial fiber optics, and motion control encoders and subsystems; light emitting diode, ethernet PHYs, switch ICs, and camera microcontrollers. Its products are used in various applications, including enterprise and data center networking, home connectivity, set-top boxes, broadband access, telecommunication equipment, smartphones and base stations, data center servers and storage systems, factory automation, power generation and alternative energy systems, and electronic displays. Broadcom Inc. was incorporated in 2018 and is headquartered in San Jose, California.

NASDAQ ended the session with Broadcom jumping 4.35% to $912.57 on Thursday while NASDAQ slid 0.63% to $13,574.22.

Earnings Per Share

As for profitability, Broadcom has a trailing twelve months EPS of $32.53.

PE Ratio

Broadcom has a trailing twelve months price to earnings ratio of 28.05. Meaning, the purchaser of the share is investing $28.05 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 64.76%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 0.6% and positive 1.9% for the next.

More news about Broadcom.

5. Vmware (VMW) – 3.8%

VMware, Inc. provides software solutions in the areas of modern applications, cloud management and infrastructure, networking, security, and workspaces in the United States and internationally. It offers VMware multi-cloud solutions, including VMware vSphere, a data center infrastructure that provides the fundamental compute layer; and vSAN and VxRail, which offers holistic data storage and protection options to applications running on vSphere; as well as VMware Cloud Foundation, a cloud platform that combines its vSphere, vSAN, and NSX with VMware Aria Cloud Management into an integrated stack that delivers ready cloud infrastructure for private and public clouds. The company also provides networking solutions, such as VMware NSX, NSX Distributed and Gateway Firewalls, NSX Network Detection and Response Engine, NSX Advanced Load Balancer, Tanzu Service Mesh, HCX, and VMware SASE; security solutions consisting of VMware Carbon Black Endpoint, Workload, and Container; and anywhere workspace solutions comprising Workspace ONE Unified Endpoint Management, Access, Intelligent Hub, Horizon, Mobile Threat Defence, and Digital Employee Experience Management. In addition, it offers application modernization solutions, such as Tanzu Application and Operations Platform, Tanzu Application Service, Tanzu Data Suite, and Tanzu Labs; and cloud management solutions, including VMware Aria Cloud Management, VMware Aria Suite, VMware Aria Universal Suite, and vCloud Suite. The company sells its products through distributors, resellers, system vendors, systems integrators, and contractors. VMware, Inc. has a strategic alliance with Amazon Web Services to build and deliver an integrated hybrid solution. VMware, Inc. was incorporated in 1998 and is headquartered in Palo Alto, California.

NYSE ended the session with Vmware rising 3.8% to $178.00 on Thursday while NYSE dropped 1.02% to $15,329.55.

Earnings Per Share

As for profitability, Vmware has a trailing twelve months EPS of $3.33.

PE Ratio

Vmware has a trailing twelve months price to earnings ratio of 53.45. Meaning, the purchaser of the share is investing $53.45 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 106.14%.

Volatility

Vmware’s last week, last month’s, and last quarter’s current intraday variation average was 0.83%, 0.11%, and 0.96%.

Vmware’s highest amplitude of average volatility was 0.83% (last week), 0.86% (last month), and 0.96% (last quarter).

Volume

Today’s last reported volume for Vmware is 3344040 which is 101.18% above its average volume of 1662140.

More news about Vmware.

6. KLA Corporation (KLAC) – 3.76%

KLA Corporation designs, manufactures, and markets process control, process-enabling, and yield management solutions for the semiconductor and related electronics industries worldwide. It operates through three segments: Semiconductor Process Control; Specialty Semiconductor Process; and PCB, Display and Component Inspection. The company offers inspection and review tools to identify, locate, characterize, review, and analyze defects on various surfaces of patterned and unpatterned wafers; metrology systems that are used to measure pattern dimensions, film thickness, film stress, layer-to-layer alignment, pattern placement, surface topography, and electro-optical properties for wafers; Wafer defect inspection, review, and metrology systems; reticle inspection and metrology systems; chemical process control equipment; wired and wireless sensor wafers and reticles; and semiconductor software solutions that provide run-time process control, defect excursion identification, process corrections, and defect classification to accelerate yield learning rates and reduce production risk. It also provides etch, plasma dicing, deposition, and other wafer processing technologies and solutions for the semiconductor and microelectronics industry. In addition, the company offers direct imaging, inspection, optical shaping, inkjet and additive printing, UV laser drilling and computer-aided manufacturing and engineering solutions for the PCB market; inspection and electrical testing systems to identify and classify defects, as well as systems to repair defects for the display market; and inspection and metrology systems for quality control and yield improvement in advanced and traditional semiconductor packaging markets. The company was formerly known as KLA-Tencor Corporation and changed its name to KLA Corporation in July 2019. KLA Corporation was incorporated in 1975 and is headquartered in Milpitas, California.

NASDAQ ended the session with KLA Corporation jumping 3.76% to $500.76 on Thursday, after two successive sessions in a row of gains. NASDAQ dropped 0.63% to $13,574.22, after four sequential sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, KLA Corporation has a trailing twelve months EPS of $24.13.

PE Ratio

KLA Corporation has a trailing twelve months price to earnings ratio of 20.75. Meaning, the purchaser of the share is investing $20.75 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 156.86%.

Yearly Top and Bottom Value

KLA Corporation ‘s stock is valued at $500.76 at 17:32 EST, under its 52-week high of $520.19 and way higher than its 52-week low of $250.20.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 23.4% and a negative 25.3%, respectively.

Volatility

KLA Corporation ‘s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.94%, a negative 0.13%, and a positive 1.57%.

KLA Corporation ‘s highest amplitude of average volatility was 1.12% (last week), 1.24% (last month), and 1.57% (last quarter).

Sales Growth

KLA Corporation ‘s sales growth for the current quarter is negative 9%.

More news about KLA Corporation .

7. Albemarle (ALB) – 3.7%

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based products used in fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

NYSE ended the session with Albemarle rising 3.7% to $170.90 on Thursday, after two consecutive sessions in a row of gains. NYSE fell 1.02% to $15,329.55, after five consecutive sessions in a row of gains, on what was an all-around down trend trading session today.

Earnings Per Share

As for profitability, Albemarle has a trailing twelve months EPS of $33.26.

PE Ratio

Albemarle has a trailing twelve months price to earnings ratio of 5.14. Meaning, the purchaser of the share is investing $5.14 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 49.38%.

Volatility

Albemarle’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.51%, a negative 0.65%, and a positive 1.66%.

Albemarle’s highest amplitude of average volatility was 3.26% (last week), 2.10% (last month), and 1.66% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 60.2%, now sitting on 9.66B for the twelve trailing months.

Moving Average

Albemarle’s worth is below its 50-day moving average of $184.70 and way under its 200-day moving average of $215.41.

More news about Albemarle.

8. Owens (OI) – 3.69%

O-I Glass, Inc., through its subsidiaries, engages in the manufacture and sale of glass containers to food and beverage manufacturers primarily in the Americas, Europe, and internationally. The company produces glass containers for alcoholic beverages, including beer, flavored malt beverages, spirits, and wine. It is also involved in the production of glass packaging for various food items, soft drinks, tea, juices, and pharmaceuticals. In addition, the company offers glass containers in a range of sizes, shapes, and colors. It sells its products directly to customers under annual or multi-year supply agreements, as well as through distributors. The company was founded in 1903 and is headquartered in Perrysburg, Ohio.

NYSE ended the session with Owens rising 3.69% to $16.31 on Thursday, after three successive sessions in a row of gains. NYSE fell 1.02% to $15,329.55, after five consecutive sessions in a row of gains, on what was an all-around down trend trading session today.

Earnings Per Share

As for profitability, Owens has a trailing twelve months EPS of $3.51.

PE Ratio

Owens has a trailing twelve months price to earnings ratio of 4.65. Meaning, the purchaser of the share is investing $4.65 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.63%.

Previous days news about Owens

• Owens corning (oc) surpasses market returns: some facts worth knowing. According to Zacks on Tuesday, 10 October, "Investors should also pay attention to any latest changes in analyst estimates for Owens Corning. ", "Investors will be eagerly watching for the performance of Owens Corning in its upcoming earnings disclosure. "

More news about Owens.

9. Paramount Group (PGRE) – 3.67%

Headquartered in New York City, Paramount Group, Inc. is a fully-integrated real estate investment trust that owns, operates, manages, acquires and redevelops high-quality, Class A office properties located in select central business district submarkets of New York City and San Francisco. Paramount is focused on maximizing the value of its portfolio by leveraging the sought-after locations of its assets and its proven property management capabilities to attract and retain high-quality tenants.

NYSE ended the session with Paramount Group rising 3.67% to $4.52 on Thursday while NYSE dropped 1.02% to $15,329.55.

Earnings Per Share

As for profitability, Paramount Group has a trailing twelve months EPS of $-0.39.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.57%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 300% and a negative 150%, respectively.

Yearly Top and Bottom Value

Paramount Group’s stock is valued at $4.52 at 17:32 EST, way below its 52-week high of $6.86 and way higher than its 52-week low of $3.90.

More news about Paramount Group.

10. Pampa Energia S.A. Pampa Energia S.A. (PAM) – 3.41%

Pampa Energía S.A. operates as an independent energy integrated company in Argentina. The company operates through Electricity Generation, Oil and Gas, Petrochemicals, and Holding and Other Business segments. It generates electricity through thermal generation plants, thermal gas-fired thermal generation plants, and hydroelectric power generation systems, as well as through a wind farm. The company also explores for and produces oil and gas; produces petrochemicals, such as styrene, styrene butadiene rubber, and polystyrene; and operates high voltage electricity transmission network. In addition, it engages in gas transportation and advisory services activities. The company was formerly known as Pampa Holding S.A. and changed its name to Pampa Energía S.A. in September 2008. Pampa Energía S.A. was incorporated in 1945 and is based in Buenos Aires, Argentina.

NYSE ended the session with Pampa Energia S.A. Pampa Energia S.A. jumping 3.41% to $40.94 on Thursday, after five sequential sessions in a row of gains. NYSE fell 1.02% to $15,329.55, after five successive sessions in a row of gains, on what was an all-around bearish trend exchanging session today.

Earnings Per Share

As for profitability, Pampa Energia S.A. Pampa Energia S.A. has a trailing twelve months EPS of $11.06.

PE Ratio

Pampa Energia S.A. Pampa Energia S.A. has a trailing twelve months price to earnings ratio of 3.7. Meaning, the purchaser of the share is investing $3.7 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.37%.

Sales Growth

Pampa Energia S.A. Pampa Energia S.A.’s sales growth is 7.5% for the ongoing quarter and 7.8% for the next.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is 66.7% and a drop 64.4% for the next.

More news about Pampa Energia S.A. Pampa Energia S.A..

Losers Today

1. Gevo (GEVO) – -10.83%

Gevo, Inc. operates as a renewable fuels company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company offers renewable gasoline and diesel, isooctane, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.

NASDAQ ended the session with Gevo dropping 10.83% to $1.07 on Thursday, after two sequential sessions in a row of gains. NASDAQ fell 0.63% to $13,574.22, after four successive sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Gevo has a trailing twelve months EPS of $-0.48.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.23%.

Volatility

Gevo’s last week, last month’s, and last quarter’s current intraday variation average was a positive 4.28%, a negative 0.80%, and a positive 3.42%.

Gevo’s highest amplitude of average volatility was 7.58% (last week), 3.75% (last month), and 3.42% (last quarter).

More news about Gevo.

2. FibroGen (FGEN) – -10.4%

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

NASDAQ ended the session with FibroGen sliding 10.4% to $0.63 on Thursday, following the last session’s downward trend. NASDAQ slid 0.63% to $13,574.22, after four sequential sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, FibroGen has a trailing twelve months EPS of $-3.72.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1015.79%.

More news about FibroGen.

3. Hormel Foods (HRL) – -10.23%

Hormel Foods Corporation develops, processes, and distributes various meat, nuts, and food products to retail, foodservice, deli, and commercial customers in the United States and internationally. The company operates through four segments: Grocery Products, Refrigerated Foods, Jennie-O Turkey Store, and International & Other. It provides various perishable products that include fresh meats, frozen items, refrigerated meal solutions, sausages, hams, guacamoles, and bacons; and shelf-stable products comprising canned luncheon meats, nut butters, snack nuts, chilies, shelf-stable microwaveable meals, hashes, stews, tortillas, salsas, tortilla chips, and others. The company also engages in the processing, marketing, and sale of branded and unbranded pork, beef, poultry, and turkey products, as well as offers nutritional food products and supplements, desserts and drink mixes, and industrial gelatin products. It sells its products primarily under the SKIPPY, SPAM, Hormel, Natural Choice, Applegate, Justin's, Jennie-O, Café H, Herdez, Black Label, Sadler's, Columbus, Gatherings, Herdez, Wholly, Columbus, Planters, NUT-rition, Planters Cheez Balls, Corn Nuts, etc. brand names through sales personnel, independent brokers, and distributors. The company was formerly known as Geo. A. Hormel & Company and changed its name to Hormel Foods Corporation in January 1995. Hormel Foods Corporation was founded in 1891 and is headquartered in Austin, Minnesota.

NYSE ended the session with Hormel Foods falling 10.23% to $32.53 on Thursday, after two sequential sessions in a row of losses. NYSE slid 1.02% to $15,329.55, after five sequential sessions in a row of gains, on what was an all-around negative trend exchanging session today.

Bear of the day: hormel foods (hrl)With rapidly shifting food preferences from consumers, and stiff competition Hormel Foods is dealing with a challenging road ahead. , By no means do I think Hormel Foods is going to go the way of the dodo bird, but at this point it is definitely a stock I think investors should avoid.

Earnings Per Share

As for profitability, Hormel Foods has a trailing twelve months EPS of $1.6.

PE Ratio

Hormel Foods has a trailing twelve months price to earnings ratio of 20.33. Meaning, the purchaser of the share is investing $20.33 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.63%.

Volatility

Hormel Foods’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.01%, a negative 0.13%, and a positive 0.98%.

Hormel Foods’s highest amplitude of average volatility was 1.85% (last week), 1.03% (last month), and 0.98% (last quarter).

Yearly Top and Bottom Value

Hormel Foods’s stock is valued at $32.53 at 17:32 EST, below its 52-week low of $35.96.

Previous days news about Hormel Foods

• Hormel foods (hrl) battles supply-chain issues & high costs. According to Zacks on Wednesday, 11 October, "Whether the upsides can help Hormel Foods stay afloat amid hurdles is yet to be seen."

More news about Hormel Foods.

4. Castle Biosciences (CSTL) – -9.03%

Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary 35-GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.

NASDAQ ended the session with Castle Biosciences dropping 9.03% to $12.39 on Thursday, following the last session’s downward trend. NASDAQ dropped 0.63% to $13,574.22, after four consecutive sessions in a row of gains, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, Castle Biosciences has a trailing twelve months EPS of $-3.41.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -22.2%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Castle Biosciences’s stock is considered to be oversold (<=20).

Volatility

Castle Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.41%, a negative 1.16%, and a positive 2.57%.

Castle Biosciences’s highest amplitude of average volatility was 1.90% (last week), 2.56% (last month), and 2.57% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 43.9%, now sitting on 167.52M for the twelve trailing months.

More news about Castle Biosciences.

5. Rayonier Advanced Materials (RYAM) – -8.89%

Rayonier Advanced Materials Inc. manufactures and sells cellulose specialty products in the United States, China, Canada, Japan, Europe, Latin America, other Asian countries, and internationally. The company operates through High Purity Cellulose, Paperboard, and High-Yield Pulp segments. Its products include cellulose specialties, which are natural polymers that are used as raw materials to manufacture a range of consumer-oriented products, such as liquid crystal displays, impact-resistant plastics, thickeners for food products, pharmaceuticals, cosmetics, cigarette filters, high-tenacity rayon yarn for tires and industrial hoses, food casings, paints, and lacquers. The company also offers commodity products, such as commodity viscose pulp used in woven applications, including rayon textiles for clothing and other fabrics, as well as in non-woven applications comprising baby wipes, cosmetic and personal wipes, industrial wipes, and mattress ticking; and absorbent materials consisting of fluff fibers that are used as an absorbent medium in disposable baby diapers, feminine hygiene products, incontinence pads, convalescent bed pads, industrial towels and wipes, and non-woven fabrics. In addition, it provides paperboards for packaging, printing documents, brochures, promotional materials, paperback books and catalog covers, file folders, tags, and lottery tickets; and high-yield pulps to produce paperboard and packaging products, printing and writing papers, and various other paper products. The company was founded in 1926 and is headquartered in Jacksonville, Florida.

NYSE ended the session with Rayonier Advanced Materials sliding 8.89% to $2.87 on Thursday while NYSE dropped 1.02% to $15,329.55.

Earnings Per Share

As for profitability, Rayonier Advanced Materials has a trailing twelve months EPS of $0.13.

PE Ratio

Rayonier Advanced Materials has a trailing twelve months price to earnings ratio of 22.08. Meaning, the purchaser of the share is investing $22.08 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.01%.

Volume

Today’s last reported volume for Rayonier Advanced Materials is 947100 which is 4.23% below its average volume of 988943.

Sales Growth

Rayonier Advanced Materials’s sales growth is negative 6.5% for the current quarter and negative 16.6% for the next.

More news about Rayonier Advanced Materials.

6. American Public Education (APEI) – -8.51%

American Public Education, Inc., together with its subsidiaries, provides online and campus-based postsecondary education and career learning. It operates through three segments: American Public University System, Rasmussen University, and Hondros College of Nursing. The company offers 136 degree programs and 115 certificate programs in various fields of study, including nursing, public health, public administration, and business administration. It also provides nursing-and health sciences-focused postsecondary education, diploma in practical nursing, and an associate degree in nursing. The company was incorporated in 1991 and is headquartered in Charles Town, West Virginia.

NASDAQ ended the session with American Public Education falling 8.51% to $4.41 on Thursday, after two successive sessions in a row of gains. NASDAQ fell 0.63% to $13,574.22, after four consecutive sessions in a row of gains, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, American Public Education has a trailing twelve months EPS of $-3.82.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -22.39%.

Sales Growth

American Public Education’s sales growth is 1.8% for the ongoing quarter and negative 0.6% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 1.6%, now sitting on 598.88M for the twelve trailing months.

Yearly Top and Bottom Value

American Public Education’s stock is valued at $4.41 at 17:32 EST, way under its 52-week high of $14.22 and way higher than its 52-week low of $3.76.

More news about American Public Education.

7. Peloton (PTON) – -8.49%

Peloton Interactive, Inc. operates interactive fitness platform in North America and internationally. The company offers connected fitness products with touchscreen that streams live and on-demand classes under the Peloton Bike, Peloton Bike+, Peloton Tread, Peloton Tread+, Peloton Guide, and Peloton Row names. The company markets and sells its interactive fitness products directly through its retail showrooms and at onepeloton.com. Peloton Interactive, Inc. was founded in 2012 and is headquartered in New York, New York.

NASDAQ ended the session with Peloton dropping 8.49% to $5.01 on Thursday while NASDAQ dropped 0.63% to $13,574.22.

Earnings Per Share

As for profitability, Peloton has a trailing twelve months EPS of $-3.7.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -847.35%.

Moving Average

Peloton’s worth is way below its 50-day moving average of $6.33 and way under its 200-day moving average of $9.08.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 70% and 56.1%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth declined by 5.4%, now sitting on 2.8B for the twelve trailing months.

More news about Peloton.

8. Pacific Biosciences of California (PACB) – -8.47%

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

NASDAQ ended the session with Pacific Biosciences of California sliding 8.47% to $8.27 on Thursday while NASDAQ fell 0.63% to $13,574.22.

Earnings Per Share

As for profitability, Pacific Biosciences of California has a trailing twelve months EPS of $-1.42.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.22%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 2.9% and 21.6%, respectively.

Moving Average

Pacific Biosciences of California’s value is way under its 50-day moving average of $10.43 and way below its 200-day moving average of $10.99.

More news about Pacific Biosciences of California.

9. Nevro Corp. (NVRO) – -8.19%

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation system for the treatment of chronic pain, as well as Senza II and Senza Omnia SCS systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company's Senza HFX iQ IPG system includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system. In addition, it offers surpass surgical and percutaneous leads. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

NYSE ended the session with Nevro Corp. falling 8.19% to $17.27 on Thursday, following the last session’s downward trend. NYSE slid 1.02% to $15,329.55, after five sequential sessions in a row of gains, on what was an all-around down trend trading session today.

Earnings Per Share

As for profitability, Nevro Corp. has a trailing twelve months EPS of $0.11.

PE Ratio

Nevro Corp. has a trailing twelve months price to earnings ratio of 157. Meaning, the purchaser of the share is investing $157 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.98%.

More news about Nevro Corp..

10. JD.com (JD) – -7.76%

JD.com, Inc. provides supply chain-based technologies and services in the People's Republic of China. The company offers computers, communication, and consumer electronics products, as well as home appliances; and general merchandise products comprising food, beverage and fresh produce, baby and maternity products, furniture and household goods, cosmetics and other personal care items, pharmaceutical and healthcare products, industrial products, books, automobile accessories, apparel and footwear, bags, and jewelry. It also provides online marketplace services for third-party merchants; marketing services; and omni-channel solutions to customers and offline retailers, as well as online healthcare services. In addition, the company develops, owns, and manages its logistics facilities and other real estate properties to support third parties; offers asset management services for logistics property investors and the sale of development properties; and engages in online retail business. Further, it provides integrated data, technology, business, and user management industry solutions to support the digitization of enterprises and institutions. The company was formerly known as 360buy Jingdong Inc. and changed its name to JD.com, Inc. in January 2014. JD.com, Inc. was incorporated in 2006 and is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with JD.com sliding 7.76% to $27.99 on Thursday while NASDAQ fell 0.63% to $13,574.22.

Earnings Per Share

As for profitability, JD.com has a trailing twelve months EPS of $1.87.

PE Ratio

JD.com has a trailing twelve months price to earnings ratio of 14.97. Meaning, the purchaser of the share is investing $14.97 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.27%.

More news about JD.com.

Stay up to date with our winners and losers daily report